 |
TAG |
Articles
Strategy L/S China through regulatory and business upheaval
Trading conditions in China have severely deteriorated. After reaching their peak by mid-February, stocks lost earlier gains in March, on evidence of a plateauing economy and as stretched investors’ positioning unwounded. Chinese markets were then stuck in a volatile trading (...)
Strategy Mega Mergers to keep fueling Risk Arbitrage
With risk assets back to record highs, markets are currently looking for the next catalyst that would push equities higher. But with the Fed potentially signaling a looming reduction in asset purchases at the next FOMC meeting on June 16, it seems wise to remove some risk (...)
Strategy CTAs add value in the new correlation regime
With bond yields facing upward pressures as the global economy heats up, finding diversification across traditional asset classes has been increasingly difficult. Equity valuations, which were propelled by low interest rates in the past decade, are vulnerable in the face of (...)
Strategy Value, Momentum and the Outlook for Market Neutral L/S
Momentum stocks experienced a correction since Pfizer announced their Covid-19 vaccine results early November. Performance has nonetheless stabilized over the course of March, as the rebound in Value stocks has been persistent and started to be shown in the Momentum risk (...)
Strategy Market neutral l/sto remain under pressure
In recent months, Market Neutral L/S strategies underperformed other hedge fund strategies, in a context where risk assets rallied following the Pfizer vaccine announcement in November 2020. While the strategy is not designed to capture the equity market beta, the alpha (...)
RSS Feeds
 | News Feed |
| Jobs & Internships |
| Trainings |
|
|